CNS Pharmaceuticals Inc CNSP:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EDT
1.53quote price arrow down-0.02 (-1.29%)
Volume
35,297
52 week range
1.39 - 4.46
Loading...
  • Open1.56
  • Day High1.56
  • Day Low1.51
  • Prev Close1.55
  • 52 Week High4.46
  • 52 Week High Date02/08/21
  • 52 Week Low1.39
  • 52 Week Low Date08/20/21

Key Stats

  • Market Cap42.01M
  • Shares Out27.46M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-14.04

KEY STATS

  • Open1.56
  • Day High1.56
  • Day Low1.51
  • Prev Close1.55
  • 52 Week High4.46
  • 52 Week High Date02/08/21
  • 52 Week Low1.39
  • 52 Week Low Date08/20/21
  • Market Cap42.01M
  • Shares Out27.46M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-14.04

RATIOS/PROFITABILITY

  • EPS (TTM)-0.59
  • P/E (TTM)-2.57
  • Fwd P/E (NTM)-2.21
  • EBITDA (MRQ)-12.421M
  • ROE (MRQ)-154.26%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)1.43%

EVENTS

  • Earnings Date12/01/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On CNS Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
CNS Pharmaceuticals Inc. is a preclinical stage pharmaceutical company. The Company is focused on developing anticancer drug candidates for the treatment of brain and central nervous system tumors. The Company is focused on developing its lead drug candidate, Berubicin for the treatment of glioblastoma. Glioblastoma are tumors that arise from astrocytes, which are star-shaped cells making up the supportive tissue of the brain. Berubicin is an anthracycline, a class of drugs...
Address
2100 West Loop S Ste 900
Houston, TX
77027-3522
United States

Top Peers

SYMBOLLASTCHG%CHG
BLPH
Bellerophon Therapeutics Inc
3.84UNCHUNCH
ARDS
Aridis Pharmaceuticals Inc
3.89-0.11-2.75%
AZRX
AzurRx BioPharma Inc
3.84-0.10-2.54%
NNVC
NanoViricides Inc
4.08-0.17-4.00%
BPTH
Bio Path Holdings Inc
5.35+0.15+2.88%